Genpact (G) said Thursday it has renewed a collaboration with Ferring Pharmaceuticals to support Ferring's finance, accounting and procurement operations using technologies including artificial intelligence.
Genpact will work with Xelix and Blackline (BL) to automate various processes such as managing invoices and procurement tasks that will provide "significant operational savings," the company said.
Financial details were not disclosed.
Price: 45.10, Change: +0.46, Percent Change: +1.03
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments